Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus C, Denmark.
Department of Obstetrics and Gynaecology, Horsens Regional Hospital, Horsens, Denmark.
Hum Reprod. 2022 Oct 31;37(11):2623-2634. doi: 10.1093/humrep/deac197.
Does maternal polycystic ovarian syndrome (PCOS) affect the timing of pubertal development in daughters and sons?
Maternal PCOS was associated with earlier adrenarche in daughters.
Female adolescents with PCOS often experience earlier adrenarche compared to adolescents without PCOS, due to hyperandrogenism. Likewise, they usually have hyperandrogenism during pregnancy, which might potentially affect the development of the foetus, including its future reproductive health.
STUDY DESIGN, SIZE, DURATION: In this population-based cohort study, we included 15 596 mothers-child pairs from the Danish National Birth Cohort (DNBC) Puberty Cohort, who were followed from foetal life until full sexual maturation or 18 years of age.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Using register-based and self-reported information on maternal PCOS and menstrual irregularities, collected during pregnancy, we categorized the mothers as having PCOS (n = 251), oligomenorhoea (n = 134), 'other menstrual irregularities' (n = 2411) or no menstrual abnormalities (reference group, n = 12 800). The children provided self-reported information on pubertal development every 6 months from the age of 11 years. The main outcome measures were adjusted mean age differences (in months) at attaining several individual pubertal milestones using an interval-censored regression model, as well as the average difference in age at attaining all pubertal milestones combined into a single estimate using Huber-White robust variance estimation.
We found that maternal PCOS was associated with an accelerated pubertal development in daughters with an overall average difference of -3.3 (95% CI: -6.3; -0.4) months based on all pubertal milestones compared to the reference group. When further looking into the average difference for adrenarche only (pubarche, axillary hair and acne), the average difference was -5.4 (95% CI: -8.7; -2.1) months compared to the reference group; whereas thelarche and menarche did not occur earlier in daughters of mothers with PCOS (average difference: -0.8 (95% CI: -3.9; 2.4) months). Oligomenorrhoea and 'other menstrual irregularities' were not associated with pubertal development in daughters. Neither PCOS, oligomenorrhoea nor 'other menstrual irregularities' were associated with pubertal development in sons.
LIMITATIONS, REASONS FOR CAUTION: We expect some degree of non-differential misclassification of maternal PCOS and menstrual irregularities as well as pubertal development in the children.
Maternal PCOS might accelerate adrenarche in daughters. Whether this is due to genetics, epigenetics or prenatal programming by hyperandrogenism in foetal life remains unsolved. The results from the present study can be generalized to Caucasian populations.
STUDY FUNDING/COMPETING INTEREST(S): The study is funded by the Faculty of Health at Aarhus University. The authors have no financial relationships or competing interests to disclose.
N/A.
多囊卵巢综合征(PCOS)是否会影响女儿和儿子的青春期发育时间?
母亲患有 PCOS 与女儿的肾上腺早现有关。
患有 PCOS 的女性青少年通常比没有 PCOS 的青少年更早经历肾上腺早现,这是由于雄激素过多症引起的。同样,她们在怀孕期间通常也有雄激素过多症,这可能会潜在地影响胎儿的发育,包括其未来的生殖健康。
研究设计、规模和持续时间:在这项基于人群的队列研究中,我们纳入了来自丹麦国家出生队列(DNBC)青春期队列的 15596 对母亲-子女对,从胎儿期开始一直随访到完全性成熟或 18 岁。
参与者/材料、地点和方法:利用基于登记和自我报告的母亲 PCOS 和月经不规则信息(在怀孕期间收集),我们将母亲分为 PCOS(n=251)、少经(n=134)、“其他月经异常”(n=2411)或无月经异常(参考组,n=12800)。孩子们从 11 岁起每 6 个月自我报告一次青春期发育情况。主要观察指标是使用区间 censored 回归模型评估达到几个特定青春期里程碑的调整后平均年龄差异(以月为单位),以及使用 Huber-White 稳健方差估计将所有青春期里程碑结合为一个单一估计值的平均年龄差异。
我们发现,与参考组相比,母亲患有 PCOS 与女儿的青春期发育加速有关,总体平均差异为-3.3(95%CI:-6.3;-0.4)个月。当进一步关注仅肾上腺早现(阴毛早现、腋窝毛发和痤疮)的平均差异时,与参考组相比,平均差异为-5.4(95%CI:-8.7;-2.1)个月;而乳房发育和月经初潮在患有 PCOS 的母亲的女儿中并不更早出现(平均差异:-0.8(95%CI:-3.9;2.4)个月)。少经和“其他月经异常”与女儿的青春期发育无关。PCOS、少经或“其他月经异常”均与儿子的青春期发育无关。
局限性、谨慎的原因:我们预计母亲 PCOS 和月经不规则以及儿童青春期发育的一定程度的非差异错误分类。
母亲患有 PCOS 可能会加速女儿的肾上腺早现。这是由于遗传、表观遗传还是胎儿期雄激素过多症引起的产前编程仍未解决。本研究的结果可以推广到白种人群体。
研究资金/利益冲突:该研究由奥胡斯大学健康学院资助。作者没有财务关系或竞争利益需要披露。
无。